Prosecution Insights
Last updated: August 18, 2026

Examiner: NEMER, OSAMA MOHAMMAD

Tech Center 3700 • Art Units: 3771

This examiner grants 64% of resolved cases

Performance Statistics

64.3%
Allow Rate
-5.7% vs TC avg
122
Total Applications
+55.6%
Interview Lift
1158
Avg Prosecution Days
Based on 84 resolved cases, 2023–2026

Rejection Statute Breakdown

1.9%
§101 Eligibility
25.5%
§102 Novelty
46.6%
§103 Obviousness
22.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18787524 INTRAVASCULAR BLOOD FILTER Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
18214054 MEDICAL DEVICE RELEASE SYSTEM Final Rejection Boston Scientific Scimed, Inc.
18464458 Transcatheter Tools for Basilica or Lampoon Procedure and Methods of Using Same Non-Final OA St. Jude Medical, Cardiology Division, Inc.
17963359 SURGICAL CONSTRICTING DEVICES AND SURGICAL METHODS UTILIZING SAME Final Rejection Covidien LP
17784710 VIBRATIONAL WIRE GUIDE FOR CORING AND ASPIRATING A VENOUS OBSTRUCTION Final Rejection KONINKLIJKE PHILIPS N.V.
17753142 ATHERECTOMY DEVICES INCLUDING CUTTING BLADES HAVING DIFFERENT EDGE SHAPES Final Rejection KONINKLIJKE PHILIPS N.V.
18311468 DILATOR FOR VASCULAR ACCESS SYSTEMS, AND ASSOCIATED DEVICES AND METHODS Final Rejection Inari Medical, Inc.
19095338 SELF EXPANDING STENTS AND METHODS Non-Final OA Cook Medical Technologies LLC
18338819 EMBOLIC COIL DELIVERY SYSTEMS AND COMPONENTS Final Rejection Cook Medical Technologies LLC
18868616 THROMBUS REMOVAL SYSTEMS AND ASSOCIATED METHODS Non-Final OA Shifamed Holdings, LLC
18700398 ENDOVASCULAR THROMBUS SCRAPER AND RELATED METHODS Non-Final OA BARD PERIPHERAL VASCULAR, INC.
17824992 FUNNEL ASPIRATION CATHETER Non-Final OA Neuravi Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month